California Cancer Reporting System Standards, Volume III

 

Eureka Edits

IF420 CS SSF 21, TSExt Eval, LN Eval, Breast (CS)

 

Edit Sets

Eureka Hospital Transmit

Eureka Tumor Level

Eureka Admission Level

 

Fields

Behavior Code ICD-0-3 [NAACCR #523]

CS Lymph Nodes Eval [NAACCR #2840]

CS Site Specific Factor 21 [NAACCR #2875]

CS Tumor Size/Ext Eval [NAACCR #2820]

CS Site Specific Factor 25 [NAACCR #2879]

Histologic Type ICD-0-3 [NAACCR #522]

Primary Site [NAACCR #400]

 

Message

If CS Site Specific Factor 21 = [value], CS Tumor size/Ext Eval [value] or CS Lymph Node Evl [value] must = 5 or 6.

If CS Site Specific Factor 21 = [value], both CS Tumor size/Ext Eval [value] and CS Lymph Node Evl [value] must not = 5 or 6.

 

Specification

This edit applies only to cases coded using the Breast schema. If SSF 21 (Response to Neoadjuvant Therapy) indicates the patient received neoadjuvant therapy, then either Tumor Size/Ext Eval or Lymph Nodes Eval must indicate the patient received neoadjuvant therapy.  If SSF 21 indicates the patient did not receive neoadjuvant therapy, then both Tumor Size/Ext Eval and Lymph Nodes Eval must also indicate no neoadjuvant therapy.

 

This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll).  The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

 

This edit is skipped if any of the following conditions are true:

  1. CS Site-Specific Factor21 is blank or 988

  2. CS TS/Ext Eval is blank

  3. CS Lymph Nodes Eval is blank

  4. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

  5. CS schema is invalid

 

If CS schema is Breast:

If CS Site-Specific Factor21 = 010, 020, or 030 (received neoadjuvant therapy), then either CS Tumor Size/Ext Eval or CS Lymph Nodes Eval must = 5 or 6 indicating patient received neoadjuvant therapy.

If CS Site-Specific Factor21 = 987 (neoadjuvant therapy not given), then CS Tumor Size/Ext Eval and CS Lymph Nodes Eval must not = 5 or 6.

 

 

Historical Changes

In the SEER*Edits software, the title of this edit is: IF373

7/27/11 This new edit was created to comply with NAACCR 12.1.A.

04/2014

Function call to the CS Dynamic Link Library updated to call "CStage0205.dll" instead of "CStage.dll."